The immune system is a signaling network, not a dial that turns up and down. Cells communicate through cytokines and receptor cues, some pushing a response forward and others restraining it, and the balance between them is the whole game. That is why immune-directed compounds belong in a clinician's hands.
This category holds one compound. Thymosin alpha-1 is a 28-amino-acid peptide derived from prothymosin alpha and produced by the thymus, the organ where T cells mature. It was first isolated from thymic tissue in the 1970s and has been studied since as a signaling molecule rather than a drug that acts on any single target.
